Beyond obesity: Is cholesterol-induced liver injury the cause of non-alcoholic steatohepatitis?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 9, 2012, Pages 1412-1414

  Ioannou, George N ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR AGONIST; VERY LOW DENSITY LIPOPROTEIN;

DISEASE COURSE; EDITORIAL; ENVIRONMENTAL FACTOR; FATTY LIVER; HEREDITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84865373000     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07196.x     Document Type: Editorial

References (11)

1. Adams LA, Marsh JA, Ayonrinde OT etal. Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity. J. Gastroenterol. Hepatol. 2012; 27: 1520-7.
2. Valenti L, Al-Serri A, Daly AK etal. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1209-17.
3. Savard C, Tartaglione EV, Kuver R etal. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology 2012; doi: 10.1002/hep.25800 [Epub ahead of print].
4. Subramanian S, Goodspeed L, Wang SA etal. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J. Lipid Res. 2011; 52 (9): 1626-35.
5. Van Rooyen DM, Larter CZ, Haigh WG etal. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology 2011; 141: 1393-403, 1403 e1-5.
6. Wouters K, van Bilsen M, van Gorp PJ etal. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice. FEBS Lett. 2010; 584: 1001-5.
7. Ioannou GN, Morrow OB, Connole ML, Lee SP. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology 2009; 50: 175-84.
8. Yoneda M, Fujita K, Nozaki Y etal. Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: an open-label, pilot study. Hepatol. Res. 2010; 40: 613-21.
9. Park H, Shima T, Yamaguchi K etal. Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J. Gastroenterol. 2011; 46: 101-7.
10. Wouters K, van Gorp PJ, Bieghs V etal. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008; 48: 474-86.
11. Teratani T, Tomita K, Suzuki T etal. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells. Gastroenterology 2012; 142: 152-164 e10.